Editorials

Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment

Stuck between a Rock and a Hard Place

Jonathan A. Bolaños and Stephen L. Seliger
CJASN February 2021, CJN.00950121; DOI: https://doi.org/10.2215/CJN.00950121

Article Information

CJN.00950121
DOI 
https://doi.org/10.2215/CJN.00950121
PubMed 
33608263
Published By 
American Society of Nephrology
Print ISSN 
1555-9041
Online ISSN 
1555-905X
History 
  • Published online February 19, 2021.
Copyright & Usage 
Copyright © 2021 by the American Society of Nephrology

Author Information

  1. Jonathan A. Bolaños, and
  2. Stephen L. Seliger
  1. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, and Medical Care Clinical Center, Veterans Affairs Maryland Healthcare System, Baltimore, Maryland
  1. Correspondence:
    Dr. Jonathan A. Bolaños or Dr. Stephen L. Seliger, Nephrology, University of Maryland School of Medicine, 22 South Greene Street, N3W143, Baltimore, MD 21201. Email: JBolanos{at}som.umaryland.edu or sseliger{at}som.umaryland.edu

Statistics from Altmetric.com

Article usage

Article usage: February 2021 to February 2021

AbstractFullPdf
Feb 20210177122
Back to top

In this issue

View Selected Citations (0)
Print
Download PDF
Email Article
Citation Tools
Request Permissions
Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment
Jonathan A. Bolaños, Stephen L. Seliger
CJASN Feb 2021, CJN.00950121; DOI: 10.2215/CJN.00950121
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords